FDA
approval
· 2025-11-20
FDA Approved: PALYNZIQ — Supplemental Application (BioMarin Pharmaceutical Inc.)
Summary
The FDA approved a supplemental application for Palynziq (pegvaliase-pqpz) from BioMarin Pharmaceutical.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PALYNZIQ (PEGVALIASE-PQPZ)